Document is current
Any future updates will be listed below
-
Authors
Khadhraoui, Eya
Müller, Sebastian Johannes
Hansen, Niels
Riedel, Christian Heiner
Langer, Philip
Timäeus, Charles
Wiltfang, Jens
Bouter, Caroline
Lange, Claudia
Ernst, Marielle
-
Funding
Funding for this research was provided by:
Georg-August-Universität Göttingen
- License Information
-
More Information
Article History
Received: 4 December 2021
Accepted: 14 March 2022
First Online: 24 March 2022
Declarations
:
: This study was ethically approved by the institutional review board of the University Medical Center Göttingen (No. 10/12/2019, “Ethics Committee of the University of Göttingen”, Von-Siebold-Str. 4, 37075 Göttingen, Germany) and adhered to the 2013 Helsinki Declaration.Due to the retrospective, observational nature of the study, the ethics committee (“Ethics Committee of the University of Göttingen”) waived the need for informed consent.
: Not applicable.
: The authors declare that they have no competing interests JW is an advisory board member of Abbott, Biogen, Boehringer Ingelheim, Immunogenetics, Lilly, MSD Sharp & Dohme, and Roche Pharma. JW received honoraria for lectures from the AGNP, Actelion, Amgen, Beeijing Yibai Science and Technology Ltd., CSF-Society, Helios Klinikum Wuppertal, Janssen Cilag, Med Update GmbH, Pfizer, Roche Pharma, and Vitos Kurhessen-Bad Emstal. JW holds the following patents: PCT/EP 2011 001724 and PCT/EP 2015 052945.
